Riskpilot← Back to searchSign inGet full accessDOC-JENSBY ApS
APSDissolvedCVR 33033583Store Kongensgade 67BRental and operating of own or leased real estate · NACE 6820Est. 20101 employees
Revenue 2024
DKK 2M
+76% vs 2023
EBITDA margin
90.1%
+64% vs 2023
Equity ratio
53.8%
Financial strength
Net profit 2024
DKK 2,6M
+529% vs 2023
| Revenue | DKK 2M | +76% |
| EBITDA | DKK 1,8M | +64% |
| Net profit | DKK 2,6M | +529% |
| Total assets | DKK 39,7M | +14% |
| Equity | DKK 21,4M | +14% |
| Employees | 1 | — |
Legal name
DOC-JENSBY ApS
CVR number
33033583
Legal form
Anpartsselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
4. juni 2010
Share capital
DKK 400.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Address
Store Kongensgade 67B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21 | 96 | 174 | 253 | 484 | 515 | 1.098 | 1.137 | 4.363 | 1.578 | 2.838 | 1.140 | 2.008 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -5 | -31 | -20 | -40 | -44 | -40 | -39 | -200 |
| EBITDA | 21 | 96 | 174 | 253 | 484 | 510 | 771 | 981 | 4.163 | 1.303 | 2.798 | 1.101 | 1.808 |
| Depreciation & amort. | -107 | -111 | -111 | -181 | -384 | -384 | -0 | -0 | -0 | -0 | -364 | -385 | -403 |
| EBIT | -86 | -14 | 63 | 72 | 100 | 126 | 771 | 981 | 4.163 | 1.303 | 2.435 | 716 | 1.405 |
| Net financials | -103 | -79 | -101 | -173 | -354 | -350 | -475 | -518 | -663 | -555 | -363 | -189 | 3.002 |
| Profit before tax | -144 | -94 | -38 | -101 | -254 | -224 | 296 | 463 | 3.500 | 747 | 2.072 | 528 | 3.308 |
| Tax | 22 | 4 | 19 | 14 | 28 | 35 | 160 | 104 | 772 | 166 | 462 | 118 | 729 |
| Net profit | -166 | -98 | -57 | -116 | -282 | -259 | 136 | 359 | 2.729 | 582 | 1.610 | 410 | 2.579 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5.642 | 5.520 | 7.320 | 15.255 | 14.364 | 14.062 | 23.831 | 24.056 | 36.326 | 39.569 | 38.105 | 34.857 | 39.741 |
| Equity | 1.687 | 1.589 | 1.532 | 3.416 | 3.134 | 2.875 | 5.454 | 5.813 | 12.042 | 20.269 | 21.878 | 18.788 | 21.367 |
| Long-term debt | 2.969 | 2.865 | 3.300 | 10.839 | 10.776 | 10.712 | 13.696 | 13.485 | 15.666 | 13.761 | 13.514 | 13.266 | 15.410 |
| Short-term debt | 985 | 1.066 | 2.487 | 946 | 400 | 420 | 4.160 | 4.228 | 7.280 | 4.142 | 1.175 | 1.341 | 1.469 |
| Total debt | 3.955 | 3.931 | 5.787 | 11.785 | 11.177 | 11.132 | 17.857 | 17.713 | 22.946 | 17.902 | 14.689 | 14.606 | 16.879 |
EBITDA margin
90.1%
This company
15.8%
Market median
+470% vs market
20122024
Equity ratio
53.8%
This company
38.2%
Market median
+41% vs market
20122024
Return on equity
12.1%
This company
18.4%
Market median
+34% vs market
20122024
Net profit margin
128.4%
This company
8.1%
Market median
+1485% vs market
20122024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20122024
Debt / equity
0.86×
This company
0.62×
Market median
+39% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DK Management | Management | 2010 | — | — |
CK Management | Management | 2025 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JENSBY & KJERULF ApS | Company | 33.3% | 33.3% | 2010 |
DOC ApS | Company | 100.0% | 100.0% | 2017 |
BIBAWO Medical A/S | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DOC-JENSBY ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dorthe Kjerulf | Management | 0 companies |
| Christian Kjerulf-Jensen | Management | 0 companies |